172 related articles for article (PubMed ID: 35814440)
21. Long-term outcome and prognostic nomogram for intrahepatic cholangiocarcinoma after thermal ablation: a retrospective study.
Wang Y; Yuan Z; Liu B; Chen H; Yin T; Zheng J; Li W
Transl Cancer Res; 2020 Nov; 9(11):6743-6754. PubMed ID: 35117284
[TBL] [Abstract][Full Text] [Related]
22. High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma.
Song JP; Liu XZ; Chen Q; Liu YF
World J Clin Cases; 2022 Jan; 10(3):790-801. PubMed ID: 35127895
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study.
Yuan ZB; Fang HB; Feng QK; Li T; Li J
World J Gastroenterol; 2022 Apr; 28(15):1574-1587. PubMed ID: 35582131
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
[TBL] [Abstract][Full Text] [Related]
25. [A prognostic model of intrahepatic cholangiocarcinoma after curative intent resection based on Bayesian network].
Chen C; Wu YH; Zhang JW; Qiu YH; Wu H; Li Q; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang ZH
Zhonghua Wai Ke Za Zhi; 2021 Apr; 59(4):265-271. PubMed ID: 33706443
[No Abstract] [Full Text] [Related]
26. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study.
Zhang H; Li Q; Huang G; Yang Z; Chen K; Meng B; Yu H
Front Oncol; 2023; 13():1239375. PubMed ID: 37841429
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.
Jeong S; Cheng Q; Huang L; Wang J; Sha M; Tong Y; Xia L; Han L; Xi Z; Zhang J; Kong X; Gu J; Xia Q
BMC Cancer; 2017 Jul; 17(1):464. PubMed ID: 28673346
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.
Bartsch F; Hahn F; Müller L; Baumgart J; Hoppe-Lotichius M; Kloeckner R; Lang H
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):262-270. PubMed ID: 32861577
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection.
Liu H; Qiu G; Hu F; Wu H
World J Surg Oncol; 2021 Jul; 19(1):218. PubMed ID: 34284775
[TBL] [Abstract][Full Text] [Related]
31. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
Front Oncol; 2021; 11():780455. PubMed ID: 35004301
[TBL] [Abstract][Full Text] [Related]
32. A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
Yeh CN; Wang SY; Chen YY; Chen MH; Chiang KC; Cheng CT; Tsai CY; Wang CC; Yeh TS; Chen TC
Anticancer Res; 2016 Aug; 36(8):4249-58. PubMed ID: 27466540
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of preoperative peripheral blood neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase-to-platelet ratio index in patients with hepatitis B virus related intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(38):3134-3140. PubMed ID: 34674423
[No Abstract] [Full Text] [Related]
34. A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma.
Li L; Liang J; Song T; Yin S; Zeng J; Zhong Q; Feng X; Jia Z; Fan Y; Wang X; Lin T
Front Oncol; 2021; 11():656325. PubMed ID: 33937065
[TBL] [Abstract][Full Text] [Related]
35. Perineural invasion confers poorer clinical outcomes in patients with T1/T2 intrahepatic cholangiocarcinoma: a single center, retrospective cohort study.
Zou M; Sheng J; Ruan M; Zhou W; Ye F; Yang G; Qian Y; Wang J; Wang R; Liu S; Liu H
J Gastrointest Oncol; 2023 Dec; 14(6):2500-2510. PubMed ID: 38196519
[TBL] [Abstract][Full Text] [Related]
36. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
37. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
[TBL] [Abstract][Full Text] [Related]
38. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
[TBL] [Abstract][Full Text] [Related]
39. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma.
Tang Z; Liu WR; Zhou PY; Ding ZB; Jiang XF; Wang H; Tian MX; Tao CY; Fang Y; Qu WF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
J Cancer; 2019; 10(22):5575-5584. PubMed ID: 31632502
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
